{"id":26564,"date":"2022-10-26T13:02:00","date_gmt":"2022-10-26T17:02:00","guid":{"rendered":"https:\/\/www.cancerresearch.org\/?post_type=cri_news&p=26564"},"modified":"2022-10-28T17:54:11","modified_gmt":"2022-10-28T21:54:11","slug":"cancer-research-institute-to-host-annual-virtual-immunotherapy-patient-summit-on-november-11-12-2022","status":"publish","type":"cri_news","link":"https:\/\/www.cancerresearch.org\/es\/media-room\/cancer-research-institute-to-host-annual-virtual-immunotherapy-patient-summit-on-november-11-12-2022","title":{"rendered":"Cancer Research Institute to Host Annual Virtual Immunotherapy Patient Summit on November 11-12, 2022"},"content":{"rendered":"\n

Moderated by Emmy award-winning TV host, Tamron Hall, the free 2-day online event connects thousands of patients and their support networks with immunotherapy experts on the front lines of scientific discovery and progress<\/em>.<\/p>\n\n\n\n

NEW YORK, October 26, 2022 \u2013<\/strong> The Cancer Research Institute (CRI), a nonprofit organization dedicated to a world immune to cancer, will host its Virtual Immunotherapy Patient Summit<\/a> from November 11-12, 2022. This free 2-day virtual event will be moderated, once again, by Emmy Award-winning host of the Tamron Hall <\/em>television show, executive producer, philanthropist, and author, Tamron Hall. The Summit will cover the growing benefits of immunotherapy for more than ten cancer types, including information on recent breakthroughs, as well as breakout sessions led by top academic experts on the progress of immunotherapy against a wide range of cancer types. In addition, the Summit will offer participants an opportunity to receive a free and confidential one-on-one consultation with one of CRI\u2019s Clinical Trial Navigators. For more information and to register, visit summit.cancerresearch.org<\/a>.<\/p>\n\n\n\n

\u201cI am delighted to once again host CRI\u2019s Virtual Immunotherapy Patient Summit. This important event connects our loved ones battling cancer and resilient caregivers with our nation\u2019s dedicated immunotherapy experts. This debilitating disease has impacted all of us in some way or another \u2013 a friend, a parent, a colleague, or even a child. Through CRI\u2019s Summit, I am confident that together we will learn, grow, and re-energize our hopes and efforts to continue fighting cancer,\u201d Hall said.<\/p>\n\n\n\n

Nearly two million new U.S. cancer cases are expected to be diagnosed in 2022 alone,[1]<\/sup><\/a> with cancer distinguished as the second leading cause of death in the United States. Considered a potentially effective treatment for patients resistant to chemotherapy and radiation, as a complement to such treatment, or in some cases as a first-line treatment approach when proven to be more effective than conventional cancer treatments, cancer immunotherapy, also known as immuno-oncology, uses the power of the body\u2019s own immune system to prevent, control, and eliminate cancer. As a more precise, more personalized, and more effective treatment than conventional approaches \u2013 and with potentially fewer side effects \u2013 immunotherapy is already helping to extend and save the lives of millions of cancer patients worldwide. As of December 2019, the FDA has approved immunotherapies as a treatment for nearly 20 cancers as well as cancers with a specific genetic mutation.[2]<\/sup><\/a><\/p>\n\n\n\n

\u201cWe are proud to once again host this important public Summit that aims to equip patients, caregivers, and family members with the necessary information to make informed decisions about their cancer treatment journey. Working in tandem with our global network of researchers, supporters, patients, and advocates, the Cancer Research Institute continues to fund the most promising immuno-oncology research worldwide \u2013 all while promoting awareness, sharing up-to-date information, and inspiring lifelong advocacy for our mission to save more lives with immunotherapy. We invite you to participate in this year\u2019s exciting Summit and learn more about the immunotherapy treatment experience,\u201d said Jill O\u2019Donnell-Tormey, PhD, CEO and Director of Scientific Affairs at CRI.<\/p>\n\n\n\n

\u201cI have been living my life with breast cancer for two decades, moving from treatment to treatment with every progression. The opportunity to participate in an immunotherapy clinical trial was offered and I jumped at the chance. Since completing the trial, the results are \u2026 well, astonishing. My entire outlook about my health, my future, my life has changed, thanks to the groundbreaking work of the team at Mt. Sinai, led by Dr. Joshua Brody. I honestly can’t believe my scans! It’s my sincere hope that through programs like this patient summit, breast cancer navigators like me can look ahead to brighter futures,\u201d said Stephanie Gangi, breast cancer patient and author.<\/p>\n\n\n\n

From the comfort and safety of home, attendees of the free CRI Virtual Immunotherapy Patient Summit can expect to:<\/p>\n\n\n\n